Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America AI In Cancer Diagnostics Market, by End-user
1.4.2 North America AI In Cancer Diagnostics Market, by Component
1.4.3 North America AI In Cancer Diagnostics Market, by Cancer Type
1.4.4 North America AI In Cancer Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Dec – 2022, Nov) Leading Players
Chapter 4. North America AI In Cancer Diagnostics Market by End-user
4.1 North America Hospital Market by Country
4.2 North America Surgical Centers & Medical Institutes Market by Country
4.3 North America Others Market by Country
Chapter 5. North America AI In Cancer Diagnostics Market by Component
5.1 North America Software Solutions Market by Country
5.2 North America Hardware Market by Country
5.3 North America Services Market by Country
Chapter 6. North America AI In Cancer Diagnostics Market by Cancer Type
6.1 North America Breast Cancer Market by Country
6.2 North America Lung Cancer Market by Country
6.3 North America Brain Tumor Market by Country
6.4 North America Skin Cancer & Cervical Cancer Market by Country
6.5 North America Prostate & Colorectal Cancer Market by Country
6.6 North America Others Market by Country
Chapter 7. North America AI In Cancer Diagnostics Market by Country
7.1 US AI In Cancer Diagnostics Market
7.1.1 US AI In Cancer Diagnostics Market by End-user
7.1.2 US AI In Cancer Diagnostics Market by Component
7.1.3 US AI In Cancer Diagnostics Market by Cancer Type
7.2 Canada AI In Cancer Diagnostics Market
7.2.1 Canada AI In Cancer Diagnostics Market by End-user
7.2.2 Canada AI In Cancer Diagnostics Market by Component
7.2.3 Canada AI In Cancer Diagnostics Market by Cancer Type
7.3 Mexico AI In Cancer Diagnostics Market
7.3.1 Mexico AI In Cancer Diagnostics Market by End-user
7.3.2 Mexico AI In Cancer Diagnostics Market by Component
7.3.3 Mexico AI In Cancer Diagnostics Market by Cancer Type
7.4 Rest of North America AI In Cancer Diagnostics Market
7.4.1 Rest of North America AI In Cancer Diagnostics Market by End-user
7.4.2 Rest of North America AI In Cancer Diagnostics Market by Component
7.4.3 Rest of North America AI In Cancer Diagnostics Market by Cancer Type
Chapter 8. Company Profiles
8.1 Microsoft Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 SWOT Analysis
8.2 Flatiron Health (F. Hoffmann-La Roche Ltd.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 Paige AI, Inc.
8.3.1 Company Overview
8.3.2 Recent strategies and developments:
8.3.2.1 Partnerships, Collaborations, and Agreements:
8.3.2.2 Product Launches and Product Expansions:
8.4 PathAI, Inc.
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Partnerships, Collaborations, and Agreements:
8.4.2.2 Acquisition and Mergers:
8.5 Therapixel
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Product Launches and Product Expansions:
8.6 Tempus, Inc.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.7 SkinVision BV
8.7.1 Company Overview
8.8 Cancer Center Sp. z o.o.
8.8.1 Company Overview
8.9 Medial EarlySign
8.9.1 Company Overview
8.10. Kheiron Medical Technologies Limited
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
Unique Offerings 
